DocDollars

Collegium Pharmaceutical, Inc.

MA · United States · Reporting entity ID 100000151565

Total reported 2019–2025
$9.13M
#519 of 2,960 reporting companies — 0% of all reported industry payments
$8.16M in general payments across 227,520 records, plus $972K in research funding across 104 records.

How it breaks down

General payments $8,155,961
Research funding $972,260

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Collegium Pharmaceutical, Inc. reported $9.13M to US doctors and teaching hospitals from 2019 to 2025, ranking #519 of 2,960 reporting companies. 11% of that was research funding and 89% general payments such as consulting, speaking, food and travel. 227,520 general payment records and 104 research records were filed.

Common questions about Collegium Pharmaceutical, Inc.

How much has Collegium Pharmaceutical, Inc. paid US doctors?

Collegium Pharmaceutical, Inc. reported $9,128,221 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,155,961 in general payments, $972,260 in research funding.

How does Collegium Pharmaceutical, Inc. rank among drug and device companies?

It ranks #519 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Collegium Pharmaceutical, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.